Novabridge Biosciences ADR
(NBP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,360 | 0 | -206,439 | 0 | N/A |
| Depreciation Amortization | 569 | 0 | 7,425 | 0 | N/A |
| Other Working Capital | -19,669 | 0 | -44,702 | 0 | N/A |
| Other Operating Activity | -12,682 | 0 | 59,918 | 0 | 0 |
| Operating Cash Flow | $-50,142 | $0 | $-183,798 | $0 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -35,304 | N/A | N/A | N/A | N/A |
| PPE Investments | 62 | 0 | 3 | 0 | N/A |
| Net Acquisitions | N/A | 0 | 25 | 0 | N/A |
| Purchase Of Investment | -19,000 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -9 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -9 | 0 | 14,411 | 0 | 0 |
| Investing Cash Flow | $-54,251 | $0 | $14,439 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | -335 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 1,066 | 0 | 0 |
| Financing Cash Flow | $-335 | $0 | $1,066 | $0 | $N/A |
| Exchange Rate Effect | -20 | 0 | 11,896 | 0 | N/A |
| Beginning Cash Position | 310,667 | 0 | 466,311 | 0 | N/A |
| End Cash Position | 151,961 | 0 | 309,914 | 0 | N/A |
| Net Cash Flow | $-158,706 | $0 | $-156,397 | $0 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,142 | 0 | -183,798 | 0 | N/A |
| Free Cash Flow | -50,142 | 0 | -183,798 | 0 | 0 |